In this study, the combination of miR-424(322) and cisplatin indicated that miR-424(322) enhanced the efficacy of chemotherapy by regulating CD8+ T, MDSC and Treg-cell productions, activating CTL and reducing the secretion of regulatory cytokines in ID8 tumours. This evidence concerns the gene CD8A and neoplasm.